healthshots6d
HMPV vs other respiratory viruses: Is it similar to Covid-19, influenza, and RSV?
Understand how hMPV differs from other common respiratory viruses such as Covid-19, influenza, and RSV to protect your health ...
Frontiers17d
A nomogram for predicting neonatal acute respiratory distress syndrome in patients with neonatal pneumonia after 34 weeks of gestation
Significant characteristics were incorporated into multivariate logistic regression models to determine independent risk factors for acute respiratory distress syndrome in infants. The independent ...
Frontiers21d
Insights into microbial compositions of the respiratory tract of neonatal dairy calves in a longitudinal probiotic trial through 16S rRNA sequencing
While studies have characterized the calf lung bacterial profile with and without oral probiotics, simultaneous probiotic effects on the bacterial populations of multiple sites along the respiratory ...
The Hindu23d
No unusual rise in respiratory illnesses, influenza cases in India, Health Ministry says after review of Chinese surge
The recent surge of cases of respiratory illness in China is not unusual in view of the ongoing flu season, the Union Health Ministry said on Saturday, following a meeting of the joint monitoring ...
The New England Journal of Medicine26d
Neonatal Hepatitis and Biliary Atresia Associated with Trisomy 17–18 Syndrome
Among 19 autopsied cases of 17–18 trisomy syndrome, 10 confirmed by cytogenetic studies, nine diagnosed on the basis of phenotypic characteristics, seven cases of neonatal hepatitis were found ...
Scientific Research Publishing27d
Rare Case of a Newborn with Kasabach-Merritt Syndrome ()
a child born with cystic hygroma was treated with OK-432 and after 1.5 years presented with hemangiomatous lesions that evolved into respiratory failure within 48 h, which prompted the diagnosis of ...
Pharmaceutical Technology29d
AV-001 by Vasomune Therapeutics for Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syndrome: Likelihood of Approval
AV-001 is under clinical development by Vasomune Therapeutics and currently in Phase I for Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syndrome. According to GlobalData, ...